Your browser doesn't support javascript.
loading
[Immunogenicity and safety of revaccination of 23-valent pneumococcal polysaccharide vaccine in people aged 60 years and above].
Ma, Q L; Zhang, M; Liu, L J; Zhou, Y; Yuan, W; Yang, M; Liu, S X; Luo, L Y; Chen, H P; Xiao, Y H; Qi, Q; Yang, X M.
Afiliação
  • Ma QL; Sichuan Provincial Center for Disease Control and Prevention, Chengdu 610041, China.
  • Zhang M; China National Biotech Group Company Limited, Beijing 100024, China.
  • Liu LJ; Sichuan Provincial Center for Disease Control and Prevention, Chengdu 610041, China.
  • Zhou Y; Xinjin District Center for Disease Control and Prevention, Chengdu 611430, China.
  • Yuan W; Sichuan Tianfu New District Public Health Center, Chengdu 610213, China.
  • Yang M; Sichuan Provincial Center for Disease Control and Prevention, Chengdu 610041, China.
  • Liu SX; Chengdu Institute of Biological Products Co. Ltd, Sichuan Vaccine Engineering Technology Research Center, Chengdu 610023, China.
  • Luo LY; China National Biotech Group Company Limited, Beijing 100024, China.
  • Chen HP; China National Biotech Group Company Limited, Beijing 100024, China.
  • Xiao YH; China National Biotech Group Company Limited, Beijing 100024, China.
  • Qi Q; Sichuan Provincial Center for Disease Control and Prevention, Chengdu 610041, China.
  • Yang XM; China National Biotech Group Company Limited, Beijing 100024, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 44(7): 1119-1125, 2023 Jul 10.
Article em Zh | MEDLINE | ID: mdl-37482716
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Anticorpos Antibacterianos Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Anticorpos Antibacterianos Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article